192 related articles for article (PubMed ID: 21983135)
1. The application of an alanine-substituted mutant of the C-terminal fragment of Clostridium perfringens enterotoxin as a mucosal vaccine in mice.
Suzuki H; Kondoh M; Kakutani H; Yamane S; Uchida H; Hamakubo T; Yagi K
Biomaterials; 2012 Jan; 33(1):317-24. PubMed ID: 21983135
[TBL] [Abstract][Full Text] [Related]
2. The safety of a mucosal vaccine using the C-terminal fragment of Clostridium perfringens enterotoxin.
Suzuki H; Kakutani H; Kondoh M; Watari A; Yagi K
Pharmazie; 2010 Oct; 65(10):766-9. PubMed ID: 21105580
[TBL] [Abstract][Full Text] [Related]
3. Mucosal vaccination using claudin-4-targeting.
Kakutani H; Kondoh M; Fukasaka M; Suzuki H; Hamakubo T; Yagi K
Biomaterials; 2010 Jul; 31(20):5463-71. PubMed ID: 20398936
[TBL] [Abstract][Full Text] [Related]
4. A toxicological evaluation of a claudin modulator, the C-terminal fragment of Clostridium perfringens enterotoxin, in mice.
Suzuki H; Kondoh M; Li X; Takahashi A; Matsuhisa K; Matsushita K; Kakamu Y; Yamane S; Kodaka M; Isoda K; Yagi K
Pharmazie; 2011 Jul; 66(7):543-6. PubMed ID: 21812332
[TBL] [Abstract][Full Text] [Related]
5. Immunization with recombinant bivalent chimera r-Cpae confers protection against alpha toxin and enterotoxin of Clostridium perfringens type A in murine model.
Shreya D; Uppalapati SR; Kingston JJ; Sripathy MH; Batra HV
Mol Immunol; 2015 May; 65(1):51-7. PubMed ID: 25645504
[TBL] [Abstract][Full Text] [Related]
6. Development of Adjuvant-Free Bivalent Food Poisoning Vaccine by Augmenting the Antigenicity of
Suzuki H; Hosomi K; Nasu A; Kondoh M; Kunisawa J
Front Immunol; 2018; 9():2320. PubMed ID: 30356722
[No Abstract] [Full Text] [Related]
7. Tissue distribution and safety evaluation of a claudin-targeting molecule, the C-terminal fragment of Clostridium perfringens enterotoxin.
Li X; Saeki R; Watari A; Yagi K; Kondoh M
Eur J Pharm Sci; 2014 Feb; 52():132-7. PubMed ID: 24231339
[TBL] [Abstract][Full Text] [Related]
8. C-Terminal Clostridium perfringens Enterotoxin-Mediated Antigen Delivery for Nasal Pneumococcal Vaccine.
Suzuki H; Watari A; Hashimoto E; Yonemitsu M; Kiyono H; Yagi K; Kondoh M; Kunisawa J
PLoS One; 2015; 10(5):e0126352. PubMed ID: 26018248
[TBL] [Abstract][Full Text] [Related]
9. Clostridium perfringens enterotoxin-based protein engineering for the vaccine design and delivery system.
Lan H; Hosomi K; Kunisawa J
Vaccine; 2019 Sep; 37(42):6232-6239. PubMed ID: 31466706
[TBL] [Abstract][Full Text] [Related]
10. Preparation of a claudin-targeting molecule using a C-terminal fragment of Clostridium perfringens enterotoxin.
Ebihara C; Kondoh M; Hasuike N; Harada M; Mizuguchi H; Horiguchi Y; Fujii M; Watanabe Y
J Pharmacol Exp Ther; 2006 Jan; 316(1):255-60. PubMed ID: 16183701
[TBL] [Abstract][Full Text] [Related]
11. Mutated C-terminal fragments of Clostridium perfringens enterotoxin have increased affinity to claudin-4 and reversibly modulate tight junctions in vitro.
Takahashi A; Kondoh M; Uchida H; Kakamu Y; Hamakubo T; Yagi K
Biochem Biophys Res Commun; 2011 Jul; 410(3):466-70. PubMed ID: 21672529
[TBL] [Abstract][Full Text] [Related]
12. Domain mapping of a claudin-4 modulator, the C-terminal region of C-terminal fragment of Clostridium perfringens enterotoxin, by site-directed mutagenesis.
Takahashi A; Komiya E; Kakutani H; Yoshida T; Fujii M; Horiguchi Y; Mizuguchi H; Tsutsumi Y; Tsunoda S; Koizumi N; Isoda K; Yagi K; Watanabe Y; Kondoh M
Biochem Pharmacol; 2008 Apr; 75(8):1639-48. PubMed ID: 18342294
[TBL] [Abstract][Full Text] [Related]
13. Novel Clostridium perfringens enterotoxin suicide gene therapy for selective treatment of claudin-3- and -4-overexpressing tumors.
Walther W; Petkov S; Kuvardina ON; Aumann J; Kobelt D; Fichtner I; Lemm M; Piontek J; Blasig IE; Stein U; Schlag PM
Gene Ther; 2012 May; 19(5):494-503. PubMed ID: 21975465
[TBL] [Abstract][Full Text] [Related]
14. Comparison of mucosal absorption-enhancing activity between a claudin-3/-4 binder and a broadly specific claudin binder.
Matsuhisa K; Kondoh M; Suzuki H; Yagi K
Biochem Biophys Res Commun; 2012 Jun; 423(2):229-33. PubMed ID: 22659740
[TBL] [Abstract][Full Text] [Related]
15. Creation and biochemical analysis of a broad-specific claudin binder.
Takahashi A; Saito Y; Kondoh M; Matsushita K; Krug SM; Suzuki H; Tsujino H; Li X; Aoyama H; Matsuhisa K; Uno T; Fromm M; Hamakubo T; Yagi K
Biomaterials; 2012 Apr; 33(12):3464-74. PubMed ID: 22317861
[TBL] [Abstract][Full Text] [Related]
16. Potential protective immunogenicity of recombinant Clostridium perfringens α-β2-β1 fusion toxin in mice, sows and cows.
Zeng J; Deng G; Wang J; Zhou J; Liu X; Xie Q; Wang Y
Vaccine; 2011 Jul; 29(33):5459-66. PubMed ID: 21641956
[TBL] [Abstract][Full Text] [Related]
17. Role of tyrosine residues in modulation of claudin-4 by the C-terminal fragment of Clostridium perfringens enterotoxin.
Harada M; Kondoh M; Ebihara C; Takahashi A; Komiya E; Fujii M; Mizuguchi H; Tsunoda S; Horiguchi Y; Yagi K; Watanabe Y
Biochem Pharmacol; 2007 Jan; 73(2):206-14. PubMed ID: 17097620
[TBL] [Abstract][Full Text] [Related]
18. Development of a bivalent food poisoning vaccine: augmented antigenicity of the C-terminus of Clostridium perfringens enterotoxin by fusion with the B subunit of Escherichia coli Shiga toxin 2.
Hosomi K; Hinenoya A; Suzuki H; Nagatake T; Nishino T; Tojima Y; Hirata SI; Matsunaga A; Kondoh M; Yamasaki S; Kunisawa J
Int Immunol; 2019 Feb; 31(2):91-100. PubMed ID: 30329068
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of claudin-3 and claudin-4 receptors in uterine serous papillary carcinoma: novel targets for a type-specific therapy using Clostridium perfringens enterotoxin (CPE).
Santin AD; Bellone S; Marizzoni M; Palmieri M; Siegel ER; McKenney JK; Hennings L; Comper F; Bandiera E; Pecorelli S
Cancer; 2007 Apr; 109(7):1312-22. PubMed ID: 17326053
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of Clostridium perfringens enterotoxin receptors claudin-3 and claudin-4 in uterine carcinosarcomas.
Santin AD; Bellone S; Siegel ER; McKenney JK; Thomas M; Roman JJ; Burnett A; Tognon G; Bandiera E; Pecorelli S
Clin Cancer Res; 2007 Jun; 13(11):3339-46. PubMed ID: 17545541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
